Complications of Acute MI ‘My patient just had an MI, what do I need to worry about?’ Adam Watchorn Oct 6 2011 THANKS TO IAN RIGBY.

Slides:



Advertisements
Similar presentations
The Macstrak Project CCU Case Studies The following is a series of case studies to review different patient types and how they are captured on the form.
Advertisements

ACLS Medications.
Treatment of Acute Coronary Syndrome with ST elevation ESC guidelines 2008 Dr. David Tran A&E dept. FVH 22/12/09.
European Resuscitation Council
ACLS Medications and Their Use
Pharmacology I Drugs Used to Treat Arrhythmias. Arrhythmias Needing Treatment: Atrial Fibrillation/Flutter (AF) Supraventricular Tachycardia (SVT) Ventricular.
COMMIT/CCS-2 (ClOpidogrel & Metoprolol in Myocardial Infarction Trial)
What to do if called for an arrhythmia
Arrhythmias: The Good, the Bad and the Ugly
ACLS ALGORITHMS.
Management of Acute Myocardial Infarction
ACLS Update Marisha Chilcott, MD CCRMC Emergency Department.
Ventricular Arrhythmias Terry White, RN, EMT-P. Analyze the Rhythm.
Arrhythmias Medical Student Teaching Tuesday 24 th January 2012 Dr Karen Jones, SpR Emergency Medicine.
Advanced Cardiac Life Support (ACLS)
Cardiac Arrhythmias in Coronary Heart Disease SIGN 94.
Beta Blockade and the Heart John Hakim, M.D Cardiology Fellow West Virginia University Division of Cardiology.
Amiodarone Use in Cardiac Surgical Resuscitation
Bradycardia Risk of asystole? History of asystole Mobitz II AV block Any pause  3 s Complete heart block, wide QRS Adverse signs? Clinical evidence of.
PHARMAKOLOGY VASOPRESSOR DRUGS DJUDJUK RAHMAD BASUKI Lab.Anestesi dan Terapi Intensive RSSA Malang.
Therapeutic Hypothermia in Out of Hospital Cardiac Arrest towards
Management of Chronic Stable Angina AIMGP Seminar Series Mirek Otremba 2007.
What Type of Shock is This?
Management. Goals of emergency management for status epilepticus Ensure adequate brain oxygenation and cardiorespiratory function Terminate clinical and.
Number Needed to Treat. End Points Baseline Risk is the risk associated with a particular condition Baseline Risk is the risk associated with a particular.
ACLS Workshop DCH Regional Medical Center and Harrison School of Pharmacy, Auburn University.
Advanced Cardiac Life Support N.Tavakoli Assistant professor Department of Emergency Medicine Iran University of Medical Sciences.
Ventricular Dysrhythmias
Clinical Conference 10/23/ y.o. with h/o HTN, presented to Palos ER with SSCP SH: remote tob FH: no early CAD All: NKDA Meds: lisinopril 5mg.
Eugene Yevstratov MD. Sustained Ventricular Tachycardia No pulse Pulse present UnstableStable O 2 and IV access Treat as VF Lidocaine 1mg/kg Consider.
Inferior/Right Ventricular Infarction CLINICAL PRESENTATION AND TREATMENT Lady Minto Hospital Emergency Rounds February 2015 Prepared by Shane Barclay.
Vasopressors in shock Diane J Lum, PharmD, BCACP Stony Brook University Hospital 9/30/15 1.
1 Bradycardia Algorithm Review Romulo B. Babasa III, MD
“Putting it All Together” Diane E. White RN CCRN PhD.
ACLS 2010 Case Scenarios
Does early beta-blockade decrease mortality in STEMI?
Tachyarrhythmia, Cardioversion and Drugs. Learning outcomes At the end of this workshop you should: Be able to recognise types of tachyarrythmia, defined.
Management of cardiac arrest Ali Asgari, MD, PGY American Heart Association
2  Unstable :  Altered mental status  Ischemic chest discomfort  Acute heart failure  Hypotension  Other signs of shock  Symptomatic:  Palpitations.
MYOCARDIAL INFARCTION. CASE 1 Mr. A: 38 years old He smokes 1 pack of cigarettes per day He has no other past medical history 8 hours ago, he gets sharp.
What is the ideal chest compression:ventilation ratio?
Arrhythmias.
1 Case 9 Stable Tachycardias © 2001 American Heart Association.
AHA 2005 ACLS Guidelines. Increased Emphasis On: Effective CPR –“Push hard and push fast” –Chest compressions.
Frank P. Carnevale, M.D. Associate Program Director Pediatric Emergency Medicine Fellowship Women & Children’s Hospital of Buffalo State University of.
The Case for Rate Control: In the Management of Atrial Fibrillation Charles W. Clogston, M.D. Cardiologist CHI St. Vincent Heart Clinic Arkansas April.
Messy Inferior STEMI J. Jeffrey Marshall, MD, FSCAI December 8, 2012.
First Response to Cardiac Arrest Blake Wachter, MD, PhD April 2, 2016.
{ Challenging Case Presentations From South Texas Methodist Hospital REGIONAL SYSTEMS OF CARE DEMONSTRATION PROJECT: MISSION: LIFELINE™ STEMI SYSTEMS ACCELERATOR.
THE HEART’S ELECTRICAL SYSTEM Marco Perez, MD Center for Inherited Cardiovascular Disease Inherited Cardiac Arrhythmia Clinic June 20, 2013.
Management of Post MI Complications Dr. A.M. Thirugnanam MD.,FRSH.,MSICP.. Interventional Cardiologist Sreem Remedy Hospitals, Hyderabad.
Case 3 Shock-Resistant VF/Pulseless VT
Ventricular Arrhythmias:A General Cardiologist’s Assessment of Therapies in 2004 C.Richard Conti M.D. MACC.
CASE PRESENTATION Clifford J Kavinsky, MD, PHD Professor of Medicine and pediatrics Associate Director, Center for Congenital and Structural Heart Disease.
Andrew J. Bowman Acute Care Nurse Practitioner Paramedic
Assessing and treating tachyarrhythmias Workshop
CODE BLUE MANAGEMENT DRUG THERAPY
Improving Outcomes in Cardiogenic Shock
Background Information
Therapeutics Tutoring
PEA arrest: Chest compressions aren’t enough
FINESSE: Study Design Acute ST Elevation MI (or New LBBB) within 6h pain onset Presenting at Hub or Spoke with estimated time to Cath between 1 and 4 hours.
Advanced Life Support.
Cardiopulmonary Resuscitation
NAP6 – deaths, cardiac arrests, profound hypotension and outcomes Tim Cook Director of NAP program Consultant Anaesthesia/Intensive Care, Bath.
What is the relative risk reduction of ACEi’s/beta blockers for HFrEF?
Q1.
Inferior/Right Ventricular Infarction
ຊັອກ (SHOCK).
Presentation transcript:

Complications of Acute MI ‘My patient just had an MI, what do I need to worry about?’ Adam Watchorn Oct THANKS TO IAN RIGBY

Arrhythmias Cooling Shock

55F CP 3hr duration Afebrile 95 86/48 94% 2L NP Diaphoretic & Pale Cool extremities JVP normal

1)LYTICS or transfer to Cath lab (Rockyview)? 2)LYTICS or transfer to Cath lab (Golden)? 1)What PRESSOR would you use and why? What dose would you start at?

My hospital has PCI Easy choice: PCI > LYTICS (6-month mortality benefit) My hospital does NOT have PCI Tough choice: Risk vs. Benefits of LYTICS ?

Cardiogenic Shock Subset N=280 Mortality 28 day Dopamine 52% Norepinephrine 48.6% P = 0.03 Arrhythmic Events Dopamine 24% Norepinephrine 12% P < 0.001

How would you INTUBATE ? Awake vs. RSI? Induction agent and dose? Paralytic agent and dose? How would you prepare?

CHANGE IT UP A LITTLE Same Patient 86/ % 2L NP

What’s Your DDx? 1L Fluids Acute CHF Murmur

Papillary Muscle Rupture (MR) 7% of CS Inferior – Posterior 2-7d (can be acute) Acute Pulmonary Edema > 50% Mortality

Septal Rupture 4% of CS Anterior-Lateral 1d Sudden badness Holosystolic murmur Mortality > 80%

Free Wall Rupture 1.4% Anterior 1d Pericardial effusion/Tamponade > 86% Mortality

Case Summary Normal ECG excludes Cardiogenic Shock Center without PCI = Lytics on case by case basis NE > Dopamine (MAP 65) Reduce Induction doses / Pressors on board

58M 2 hr CP after hockey game Feels like old MI 2 years ago PMHx: Ischemic cardiomyopathy (EF = 30), DM, GERD Meds: ASA, Metoprolol, ACEI, Statin, Pantoprazole 110 NSR 172/92 98% 2L NP

Would you give LYTICS? (No old ECGs)

Bottom Line (non-sustained VT, PVCs, AIVR) Very Common (>50%) Does not lead to worse outcomes (VF/Mortality) No role for prophylactic treatment

Palpable pulse. Ischemic pain returns /82

What would you use to prevent another episode of VT or VF? 1)Amiodarone 150 mg IV over 10 min 2)Metoprolol 5 mg IV 3)Lidocaine 40 mg IV

Arrhythmias associated with higher Mortality (CO = SV + HR) Any Tachycardia (TOO FAST) Sinus Tachy SVT AF VT VF Blocks (TOO SLOW) 2 nd AV Block Mobitz II Complete BOTTOM LINE Fix the arrhythmia to maintain adequate CO

Develops another run of sustained VT Ischemic pain returns and he becomes altered 205, 172/76, 96% 4L NP

100J

200J

Amiodarone

360J Mg

STILL in VT: What’s your next step? 1)Shock him again at 360J 1)Repeat Amiodarone 150 mg 2)Consult Electrophysiologist 1)Amiodarone 150 mg + Metoprolol 5 mg 2)Procainamide 1000 mg

BETA BLOCKER

Case Summary Common Benign: non-sustained VT, PVC, AIVR Bad: Tachy and Brady Ventricular storm = Add a little Metoprolol to your Amiodarone

All right stop collaborate and listen Ice is back with my brand new invention Something grabs a hold of me tightly Flow like a harpoon daily and nightly Will it ever stop yo I don’t know Robert Matthew Van Winkle aka Vanilla Ice, 1989

43M White Rapper According to witnesses: ‘CP then collapsed‘ No pulse CPR by groupies at scene Rushed to FMC

PEA ROSC after 35 min. Still Unresponsive

Who should I consider for cooling? 1)43M witnessed arrest, PEA, CPR immediately, ROSC 35 min, unresponsive 2)70M witnessed pulseless VT arrest after MVA, ROSC 25 minutes, unresponsive 1)55M witnessed arrest VF, ROSC 25min, CPR within 5 min, uncontrolled VT, cardiogenic shock, unresponsive

Indications for Cooling Witnessed arrest & patient remains unresponsive CPR within 15 min ROSC < 60 min

HACA 2002 NNT 6

What about PEA & Asystole? ROSC > 25 min only 3% survive Studies show: PEA/Asystole associated with longer ROSC (32 min versus 20 min) Bottom Line: We need larger studies but for now talk to ICU/CCU

Absolute Contraindications Responds to verbal commands after ROSC Initial Temp < 30 on admission Comatose prior to arrest Pregnant Coagulopathic

Fastest method for cooling? NS Fridge 30ml/kg (2L) Pressure Bag 1C with every 1L ICE Axilla and Groin Goal 1)Start ASAP 2)33C in 6 hours

Shivering Fentanyl 50 mcg bolus then infusion AND/OR Midazolam 2-5 mg bolus then infusion Roc 0.6 mg/kg then 0.2 mg/kg PRN

How do we monitor in ED? MAP > 65 Temperature = Esophageal probe (EMcrit) VS q15min Glucose q1h ABG q2h Lytes q6h

?